Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States

OBJECTIVES: To evaluate the cost-effectiveness of a booster strategy in the United States. METHODS: We developed a decision-analytic Markov model of COVID-19 to evaluate the cost-effectiveness of a booster strategy of the Pfizer-BioNTech BNT162b2 (administered 6 months after the second dose) among o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Liu, Hanting, Fairley, Christopher K, Zou, Zhuoru, Xie, Li, Li, Xinghui, Shen, Mingwang, Li, Yan, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938315/
https://www.ncbi.nlm.nih.gov/pubmed/35338008
http://dx.doi.org/10.1016/j.ijid.2022.03.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938315/
https://www.ncbi.nlm.nih.gov/pubmed/35338008
http://dx.doi.org/10.1016/j.ijid.2022.03.029

Ejemplares similares